Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target 'Other venom toxins from Echis ocellatus, Bitis arietans, and Naja nigricollis' refers to the complex mixture of bioactive proteins and peptides found in the venoms of three medically significant African snakes: the West African carpet viper, the puff adder, and the black-necked spitting cobra [WHO Snakebite Fact Sheet]. These venoms contain several major molecular classes, including snake venom metalloproteinases (SVMPs), serine proteases, phospholipases A2 (PLA2s), and three-finger toxins (3FTxs) [UniProt]. Biologically, these toxins act synergistically to immobilize prey and initiate digestion by causing systemic hemorrhage, consumptive coagulopathy, and extensive local tissue necrosis [PubMed: 25463111]. In a clinical context, these toxins are the primary targets for polyvalent antivenoms, such as EchiTAb-Plus-ICP, which utilize purified antibodies to bind and neutralize the venom's pathological effects [The Lancet]. The therapeutic challenge in treating envenomation from these species lies in the high degree of venom variability and the need for rapid administration of potent, cross-reactive antivenoms to prevent permanent disability or death [Toxins Journal].
Antivenom antibodies bind to specific epitopes on the venom toxins, sterically hindering their interaction with physiological substrates or receptors and facilitating their clearance from circulation [PubMed: 28946615].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Venom toxins from Echis ocellatus, Bitis arietans, and Naja nigricollis.